Nantahala Capital Management - HTG MOLECULAR DIAGNOSTICS IN ownership

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q1 2022$397,000
-78.1%
285,963
-14.6%
0.02%
-71.9%
Q4 2021$1,816,000
-8.4%
335,015
-3.5%
0.06%
+3.2%
Q3 2021$1,982,000
-6.2%
347,171
-4.5%
0.06%
+3.3%
Q2 2021$2,113,000
+6.2%
363,6220.0%0.06%
+3.4%
Q1 2021$1,989,000
+14.2%
363,6220.0%0.06%
+7.4%
Q4 2020$1,742,000363,6220.05%
Other shareholders

There were no reported owners of HTG MOLECULAR DIAGNOSTICS IN in Q1 2021.

NameSharesValueWeighting ↓
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders